Facilities

Merck’s Darren Verlenden discusses the strategy and ethics behind the expansion plan in Lenexa, Kansas

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

Both the FDA and Pfizer have released statements in the aftermath of the North Carolina tornado.

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Why modular designs will be the future of advanced therapy manufacturing.

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect